Trial · NCT07897838
Neqpiaput Iinruugut (Our Food Is Medicine): A Tribally Driven Food Sovereignty Intervention to Reduce Heart Disease Risk in Alaska Native Adults
NCT07897838, Not applicable, Not yet recruiting, University of Alaska Fairbanks
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Neqpiaput Iinruugut (Our Food Is Medicine): A Tribally Driven Food Sovereignty Intervention to Reduce Heart Disease Risk in Alaska Native Adults. Trials, record NCT07897838. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07897838
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Neqpiaput Iinruugut (Our Food Is Medicine): A Tribally Driven Food Sovereignty Intervention to Reduce Heart Disease Risk in Alaska Native Adults
- NCT number
- NCT07897838
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 150 participants, estimated
- Lead sponsor
- University of Alaska Fairbanks
- Conditions
- Cardiovascular (CV) Risk
- Interventions
- Neqpiaput linruugut (Our Food is Medicine)
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Framingham Risk Score | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Estimated 10-year risk of coronary heart disease, using the Framingham Risk Score based on age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, blood pressure medication use, diabetes status, and smoking status. Total and HDL cholesterol are measured from a fasting finger-stick blood sample using a Cholestech LDX point-of-care analyzer, and blood pressure is measured using an OMRON IntelliSense professional digital monitor. Remaining inputs are self-reported on the Demographic and Medical History Questionnaire. Higher scores indicate greater estimated 10-year cardiovascular disease risk. |
| Secondary | Change in perceived stress | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Perceived stress will be assessed using the 10-item Perceived Stress Scale (PSS-10), which measures the degree to which participants perceive situations in their lives as stressful, including feelings of overload and lack of control. Higher scores indicate greater perceived stress. |
| Secondary | Change in historical loss-associated symptoms | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Historical loss-associated symptoms will be assessed using an adapted Historical Loss Associated Symptoms Scale (HLASS), which measures emotional and behavioral responses associated with thinking about historical losses, including grief, anger, shame, and feelings of loss. Higher scores indicate more frequent symptoms associated with historical loss. |
| Secondary | Change in Yup'ik wellness | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Assessed using the Yup'ik Wellness Questionnaire, which measures two dimensions of engagement with Yup'ik cultural systems: frequency of participation in cultural practices and the importance participants place on those practices. Higher frequency ratings indicate more frequent engagement, and higher importance ratings indicate greater importance placed on the activity. |
| Secondary | Change in Yup'ik cultural identity | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Cultural identity will be assessed using one item measuring the degree to which participants identify with Yup'ik way of life. Higher ratings indicate greater identification with/following of a Yup'ik way of life. |
| Secondary | Change in Kass'aq (non-Native) cultural identity | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Cultural identity will be assessed using one item measuring the degree to which participants identify with Kass'aq way of life. Higher ratings indicate greater identification with/following of a Kass'aq way of life. |
| Secondary | Change in connectedness | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Connectedness will be assessed using the Awareness of Connectedness scale, which assesses reciprocity and connectedness to family, community, and land. Higher scores indicate greater awareness of connectedness. |
| Secondary | Change in family relationship | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Family relationships are assessed using 16 items from the Brief Family Relationship Scale (BFRS) addressing family support and cohesion, communication and expressiveness, and conflict. Higher scores indicate greater cohesion and lower conflict. |
| Secondary | Change in traditional food consumption | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Traditional food consumption will be assessed using a six-item survey measuring frequency of consumption across six traditional food categories: fish, marine mammals, land mammals, wild birds or eggs, berries, and wild plants or greens. Higher responses indicate more frequent traditional food consumption. |
| Secondary | Change in Indigenous food sovereignty | Baseline (B), 6-month intervention midpoint (T1), 12-month end of intervention (T2), and 18-month follow-up (T3) | Indigenous food sovereignty is assessed using 19 items addressing subsistence knowledge and skills, teaching and learning, food sharing, relationships, access, adaptability, stewardship, and impacts of colonization and changes in traditional food systems. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers7
The papers the trial lists on ClinicalTrials.gov.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R01HL181633 | Neqpiaput Iinruugut (Our Food is Medicine): Testing a tribally-driven intervention to prevent heart disease among Alaska Native communities | BERSAMIN, ANDREA | UNIVERSITY OF ALASKA FAIRBANKS | NATIONAL HEART, LUNG, AND BLOOD INSTITUTE | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07897838
GET https://conductscience.org/api/trials/v1/NCT07897838/registered